Persistence Market Research Company
Customize Now Report Sample

Genome Editing Market Size, Share, and Growth Forecast, 2025 - 2032

Genome Editing Market By Method (Ex-Vivo, In-Vivo), Technology (CRISPR/CRISPR-Cas9, TALEN, Zinc Finger Nucleases (ZFN), Others), End-user (Pharmaceutical & Biotechnology Companies, Others), Application (Drug Discovery & Development), and Regional Analysis for 2025 - 2032

ID: PMRREP13957| 200 Pages | 15 Oct 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Genome Editing Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Tool Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Price Analysis, 2024A
    1. Key Highlights
    2. Key Factors Impacting Deployment Costs
    3. Pricing Analysis, By Technology
  5. Global Genome Editing Market Outlook
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
    3. Global Genome Editing Market Outlook: Method
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Method, 2019 - 2024
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Method, 2025 - 2032
        1. Ex-Vivo
        2. In-Vivo
      4. Market Attractiveness Analysis: Method
    4. Global Genome Editing Market Outlook: Technology
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
        1. CRISPR/CRISPR-Cas9
        2. Transcription Activator-like Effector Nucleases (TALEN)
        3. Zinc Finger Nucleases (ZFN)
        4. Meganuclease
        5. RNAi
        6. Base Editing
        7. Prime Editing
        8. Others
      4. Market Attractiveness Analysis: Technology
    5. Global Genome Editing Market Outlook: End-user
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025 - 2032
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutions
        3. Contract Research Organizations (CROs)
        4. Government Agencies
        5. Others
      4. Market Attractiveness Analysis: End-user
    6. Global Genome Editing Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025 - 2032
        1. Drug Discovery & Development
        2. Diagnostics
        3. Genetic Engineering
        4. Clinical Applications
        5. Others
      4. Market Attractiveness Analysis: Application
  6. Global Genome Editing Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
    3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Genome Editing Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Method
      3. By Technology
      4. By End-user
      5. By Application
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Method, 2025 - 2032
      1. Ex-Vivo
      2. In-Vivo
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
      1. CRISPR/CRISPR-Cas9
      2. Transcription Activator-like Effector Nucleases (TALEN)
      3. Zinc Finger Nucleases (ZFN)
      4. Meganuclease
      5. RNAi
      6. Base Editing
      7. Prime Editing
      8. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutions
      3. Contract Research Organizations (CROs)
      4. Government Agencies
      5. Others
    7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      1. Drug Discovery & Development
      2. Diagnostics
      3. Genetic Engineering
      4. Clinical Applications
      5. Others
      6. Market Attractiveness Analysis
  8. Europe Genome Editing Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Method
      3. By Technology
      4. By End-user
      5. By Application
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Method, 2025 - 2032
      1. Ex-Vivo
      2. In-Vivo 
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
      1. CRISPR/CRISPR-Cas9
      2. Transcription Activator-like Effector Nucleases (TALEN)
      3. Zinc Finger Nucleases (ZFN)
      4. Meganuclease
      5. RNAi
      6. Base Editing
      7. Prime Editing
      8. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutions
      3. Contract Research Organizations (CROs)
      4. Government Agencies
      5. Others
    7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      1. Drug Discovery & Development
      2. Diagnostics
      3. Genetic Engineering
      4. Clinical Applications
      5. Others
      6. Market Attractiveness Analysis
  9. East Asia Genome Editing Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Method
      3. By Technology
      4. By End-user
      5. By Application
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Method, 2025 - 2032
      1. Ex-Vivo
      2. In-Vivo
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
      1. CRISPR/CRISPR-Cas9
      2. Transcription Activator-like Effector Nucleases (TALEN)
      3. Zinc Finger Nucleases (ZFN)
      4. Meganuclease
      5. RNAi
      6. Base Editing
      7. Prime Editing
      8. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutions
      3. Contract Research Organizations (CROs)
      4. Government Agencies
      5. Others
    7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      1. Drug Discovery & Development
      2. Diagnostics
      3. Genetic Engineering
      4. Clinical Applications
      5. Others
    8. Market Attractiveness Analysis
  10. South Asia & Oceania Genome Editing Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Method
      3. By Technology
      4. By End-user
      5. By Application
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Method, 2025 - 2032
      1. Ex-Vivo
      2. In-Vivo
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
      1. CRISPR/CRISPR-Cas9
      2. Transcription Activator-like Effector Nucleases (TALEN)
      3. Zinc Finger Nucleases (ZFN)
      4. Meganuclease
      5. RNAi
      6. Base Editing
      7. Prime Editing
      8. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutions
      3. Contract Research Organizations (CROs)
      4. Government Agencies
      5. Others
    7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      1. Drug Discovery & Development
      2. Diagnostics
      3. Genetic Engineering
      4. Clinical Applications
      5. Others
    8. Market Attractiveness Analysis
  11. Latin America Genome Editing Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Method
      3. By Technology
      4. By End-user
      5. By Application
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Method, 2025 - 2032
      1. Ex-Vivo
      2. In-Vivo
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
      1. CRISPR/CRISPR-Cas9
      2. Transcription Activator-like Effector Nucleases (TALEN)
      3. Zinc Finger Nucleases (ZFN)
      4. Meganuclease
      5. RNAi
      6. Base Editing
      7. Prime Editing
      8. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutions
      3. Contract Research Organizations (CROs)
      4. Government Agencies
      5. Others
    7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      1. Drug Discovery & Development
      2. Diagnostics
      3. Genetic Engineering
      4. Clinical Applications
      5. Others
    8. Market Attractiveness Analysis
  12. Middle East & Africa Genome Editing Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Method
      3. By Technology
      4. By End-user
      5. By Application
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Method, 2025 - 2032
      1. Ex-Vivo
      2. In-Vivo
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025 - 2032
      1. CRISPR/CRISPR-Cas9
      2. Transcription Activator-like Effector Nucleases (TALEN)
      3. Zinc Finger Nucleases (ZFN)
      4. Meganuclease
      5. RNAi
      6. Base Editing
      7. Prime Editing
      8. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      1. Pharmaceutical & Biotechnology Companies
      2. Academic & Research Institutions
      3. Contract Research Organizations (CROs)
      4. Government Agencies
      5. Others
    7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      1. Drug Discovery & Development
      2. Diagnostics
      3. Genetic Engineering
      4. Clinical Applications
      5. Others
    8. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Thermo Fischer Scientific, Inc.
        1. Overview
        2. Segments and Methods
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Danaher Corporation
      3. Merck KGaA
      4. Takara Bio Inc.
      5. Revvity, Inc.
      6. GenScript
      7. New England Biolabs
      8. Lonza
      9. Charles River Laboratories
      10. Eurofins Scientific
      11. CRISPR Therapeutics
      12. Editas Medicine
      13. Beam Therapeutics
      14. Intellia Therapeutics
      15. Precision BioSciences
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate